Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus

Japanese Journal of Medicine
T SasakiY Ikeda

Abstract

Pravastatin, a novel inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, was administered to nine hypercholesterolemic patients with diabetes mellitus to examine its effects on diabetic nephropathy. Pravastatin treatment resulted in lowering serum total cholesterol by 22.1% on the average (p less than 0.001), and led to a significant reduction in urinary excretion of albumin and beta 2-microglobulin in patients with an elevated urinary protein excretion rate at the baseline period. But glycemic control, blood pressure, urinary excretion of creatinine and that of N-acetyl-beta-D-glucosaminidase showed no significant change during the study. These results suggest that reduction of atherogenic lipids and lipoproteins with pravastatin could alleviate diabetic glomerular injury.

Citations

Aug 12, 2008·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Kazumi Hayashi
Sep 11, 2014·Fibrogenesis & Tissue Repair·Swayam Prakash SrivastavaKeizo Kanasaki
Jun 18, 2003·The American Journal of the Medical Sciences·Errol D CrookHerman A Taylor
Jun 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R G BretzelK F Federlin
Jan 20, 1999·Kidney International·N IsmailE Ritz
Aug 26, 2004·Kidney International·Michael CusickUNKNOWN Early Treatment Diabetic Retinopathy Study Research Group
Oct 2, 2004·Kidney International·Anja S MühlfeldCharles E Alpers
Jul 21, 1999·Kidney International. Supplement·K Jandeleit-DahmM E Cooper
Sep 1, 1994·Kidney International·W F Keane
Dec 13, 2005·Kidney International. Supplement·Aleix Cases, Elisabet Coll
Mar 9, 2005·Kidney International. Supplement·Hung-Chun ChenYung-Hsiung Lai
Jul 11, 2006·Medical Hypotheses·Mark F McCarty
Mar 6, 2009·Journal of Hypertension·Tsung-Ming Lee, Nen-Chung Chang
Nov 28, 2002·Experimental Animals·Toshiaki InenagaYasuhiro Yoshikawa
Nov 6, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Wendy P BattistiWilliam E Keane
Jul 10, 2002·Hypertension·Tsung-Ming LeeChang-Her Tsai
Mar 16, 2005·Pharmacotherapy·Alan J ZillichUNKNOWN Nephrology Practice and research networks of the American college of Clinical Pharmacy
Nov 15, 2006·Clinical Transplantation·Bengt FellströmUNKNOWN Assessment of Lescol in Renal Transplantation (ALERT) study group
Jan 15, 2004·PharmacoEconomics·Jonathan D RippinStephen C Bain
Mar 10, 1999·The American Journal of Physiology·D W JohnsonC A Pollock
May 1, 1996·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·C A Reasner, R A DeFronzo
May 25, 2021·Metabolism: Clinical and Experimental·Francesco PrattichizzoAntonio Ceriello

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.